A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility

European Journal of Human Genetics

Volumn 20, Issue 6, 2012, Pages 682-689

  Sapkota, Yadav ^a,b   Robson, Paula ^b   Lai, Raymond ^b   Cass, Carol E ^a,b   MacKey, John R ^a,b   Damaraju, Sambasivarao ^a,b  

^a CROSS CANCER INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

breast cancer; DNA repair; epistasis; genetic risk; Genome wide association study

Indexed keywords

6 O METHYLGUANINE; DNA; DNA METHYLTRANSFERASE; METHYL CPG BINDING PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; PROTEIN RAD21; RNA POLYMERASE II; RNA POLYMERASE II ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASSAY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA REPAIR; EPISTASIS; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOME; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA REPLICATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; METHYL-CPG-BINDING PROTEIN 2; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

SCHIZOSACCHAROMYCES POMBE;

EID: 84861190762     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.273     Document Type: Article

References (42)

1. Byrne C, Brinton LA, Haile RW, Schairer C: Heterogeneity of the effect of family history on breast cancer risk. Epidemiology 1991; 2: 276-284.
2. Hall JM, Lee MK, Newman B,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689. (Pubitemid 120031871)
3. Wooster R, Neuhausen SL, Mangion J,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-2090. (Pubitemid 24325690)
4. Renwick A, Thompson D, Seal S,et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006; 38: 873-875. (Pubitemid 44141653)
5. CHEK2 Breast Cancer Case-Control Consortium: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10 860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet 2004; 74: 1175-1182.
6. Malkin D, Li FP, Strong LC,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-1238. (Pubitemid 120031831)
7. Rahman N, Seal S, Thompson D,et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007; 39: 165-167. (Pubitemid 46184346)
8. Seal S, Thompson D, Renwick A,et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006; 38: 1239-1241. (Pubitemid 44646283)
9. LiawD,MarshDJ,Li J,et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16: 64-67. (Pubitemid 27198157)
10. Easton DF: How many more breast cancer predisposition genes are there? Breast Cancer Res 1999; 1: 14-17. (Pubitemid 32223529)
11. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA: Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-36.
12. Ahmed S, Thomas G, Ghoussaini M,et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009; 41: 585-590.
13. Easton DF, Pooley KA, Dunning AM,et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087-1093. (Pubitemid 47014426)
14. Turnbull C, Ahmed S, Morrison J,et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010; 42: 504-507.
15. Robinson R: Common disease, multiple rare (and distant) variants. PLoS Biol 2010; 8: e1000293.
16. Eichler EE, Flint J, Gibson G,et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 2010; 11: 446-450.
17. Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B: Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 2005; 28: 207-219. (Pubitemid 40404575)
18. Zhang K, Calabrese P, Nordborg M, Sun F: Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 2002; 71: 1386-1394. (Pubitemid 36015892)
19. Lo SH, Chernoff H, Cong L, Ding Y, Zheng T: Discovering interactions among BRCA1 and other candidate genes associated with sporadic breast cancer. Proc Natl Acad Sci USA 2008; 105: 12387-12392.
20. Musani SK, Shriner D, Liu N,et al. Detection of gene x gene interactions in genome-wide association studies of human population data. Hum Hered 2007; 63: 67-84.
21. Smith TR, Levine EA, Perrier ND,et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 1200-1204. (Pubitemid 37499444)
22. Cunningham JM, Vierkant RA, Sellers TA,et al. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer 2009; 101: 1461-1468.
23. Sehrawat B, Sridharan M, Ghosh S,et al. Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Hum Genet 2011; 130: 529-537.
24. PolyomX 2001 and CBCF-TB 2005, http://www.abtumorbank.com/?about.
25. Tomorrow project 2001, http://www.albertahealthservices.ca/ tomorrowproject.asp.
26. Golden helix, inc.bozeman, MT, USA. HelixTrees software. http://www.goldenhelix. com.
27. Sole X, Guino E, Valls J, Iniesta R, Moreno V: SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006; 22: 1928-1929. (Pubitemid 44283043)
28. Mavaddat N, Dunning AM, Ponder BA, Easton DF, Pharoah PD: Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 255-259.
29. Bernstein L, Lacey Jr JV: Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? J Natl Cancer Inst 2011; 103: 451-453.
30. Menashe I, Rosenberg PS, Chen BE: PGA: power calculator for case-control genetic association analyses. BMC Genet 2008; 9: 36.
31. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
32. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434. (Pubitemid 34112296)
33. Berger J, Bird A: Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans 2005; 33: 1537-1540. (Pubitemid 41779733)
34. Tatematsu KI, Yamazaki T, Ishikawa F: MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Genes Cells 2000; 5: 677-688. (Pubitemid 30641959)
35. Zhu Y, Brown HN, Zhang Y, Holford TR, Zheng T: Genotypes and haplotypes of the methyl-CpG-binding domain 2 modify breast cancer risk dependent upon menopausal status. Breast Cancer Res 2005; 7: R745-R752.
36. Jeronimo C, Langelier MF, Zeghouf M,et al. RPAP1, a novel human RNA polymerase II-associated protein affinity purified with recombinant wild-type and mutated polymerase subunits. Mol Cell Biol 2004; 24: 7043-7058. (Pubitemid 39014432)
37. McKay MJ, Troelstra C, van der Spek P,et al. Sequence conservation of the rad21 Schizosaccharomyces pombe DNA double-strand break repair gene in human and mouse. Genomics 1996; 36: 305-315. (Pubitemid 26307493)
38. Sonoda E, Matsusaka T, Morrison C,et al. Scc1/Rad21/Mcd1 is required for sister chromatid cohesion and kinetochore function in vertebrate cells. Dev Cell 2001; 1: 759-770. (Pubitemid 33586131)
39. Sehl ME, Langer LR, Papp JC,et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res 2009; 15: 2192-2203.
40. Esteller M, Garcia-Foncillas J, Andion E,et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350-1354.
41. Han J, Tranah GJ, Hankinson SE, Samson LD, Hunter DJ: Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk. Pharmacogenet Genomics 2006; 16: 469-474. (Pubitemid 43922344)
42. Gabriel SB, Schaffner SF, Nguyen H,et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229. (Pubitemid 34680308)